Investing.com - Immatics NV reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Immatics NV announced earnings per share of €-0.32 on revenue of €15.06M. Analysts polled by Investing.com anticipated EPS of €-0.43 on revenue of €13.83M.
Immatics NV shares are down 24% from the beginning of the year, still down 27.71% from its 52 week high of €14.00 set on December 23, 2021.
Immatics NV shares lost 1.84% in intra-day trade following the report.
Immatics NV follows other major Healthcare sector earnings this month
Immatics NV's report follows an earnings beat by Eli Lilly on November 1, who reported EPS of €1.98 on revenue of €6.94B, compared to forecasts EPS of €1.91 on revenue of €6.91B.
Pfizer had beat expectations on November 1 with third quarter EPS of €1.78 on revenue of €22.6B, compared to forecast for EPS of €1.44 on revenue of €21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar